Explore
Validate
LearnMAB20172
antibody from R&D Systems
Targeting: LILRB1
CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB
Western blot
Blocking/NeutralizingAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Blocking/Neutralizing [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB20172 - Provider product page
- Provider
- R&D Systems
- Product name
- Human LILRB1/CD85j/ILT2 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects human LILRB1/CD85j/ILT2 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) ILT1, 3, 4, 5, rhLIR-6 or rhLIR-8 is observed.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
Q8NHL6- Isotype
- IgG
- Antibody clone number
- 292319
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.
Barcoding of live human peripheral blood mononuclear cells for multiplexed mass cytometry.
Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease.
Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.
Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation.
Karnell FG, Lin D, Motley S, Duhen T, Lim N, Campbell DJ, Turka LA, Maecker HT, Harris KM
Clinical and experimental immunology 2017 Sep;189(3):268-278
Clinical and experimental immunology 2017 Sep;189(3):268-278
Barcoding of live human peripheral blood mononuclear cells for multiplexed mass cytometry.
Mei HE, Leipold MD, Schulz AR, Chester C, Maecker HT
Journal of immunology (Baltimore, Md. : 1950) 2015 Feb 15;194(4):2022-31
Journal of immunology (Baltimore, Md. : 1950) 2015 Feb 15;194(4):2022-31
Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease.
Argüello RJ, Albareda MC, Alvarez MG, Bertocchi G, Armenti AH, Vigliano C, Meckert PC, Tarleton RL, Laucella SA
PloS one 2012;7(5):e35966
PloS one 2012;7(5):e35966
Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.
Godal R, Bachanova V, Gleason M, McCullar V, Yun GH, Cooley S, Verneris MR, McGlave PB, Miller JS
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010 May;16(5):612-21
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010 May;16(5):612-21
Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation.
Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B
Blood 2007 Apr 1;109(7):2806-14
Blood 2007 Apr 1;109(7):2806-14
No comments: Submit comment
Supportive validation
- Submitted by
- R&D Systems (provider)
- Main image
- Experimental details
- Cell Adhesion Mediated by LILRB1/CD85j/ILT2 and Neutralization by Human LILRB1/CD85j/ILT2 Antibody. Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera (Catalog # 2017-T2), immobilized onto a microplate, supports the adhesion of the HSB2 human peripheral blood acute lymphoblastic leukemia cell line in a dose-dependent manner (orange line), as measured by acid phosphatase activity. Adhesion elicited by Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera (10 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human LILRB1/CD85j/ILT2 Monoclonal Antibody (Catalog # MAB20172). The ND50 is typically 0.025-0.15 µg/mL.
